Secondary malignancy after treatment of Hodgkin's disease: an evolving picture
CN Coleman
JCO Jun 1 1986: 821–824. [PDF]
Analyzing the patterns of treatment failure
JH Goldie and AJ Coldman
JCO Jun 1 1986: 825–826. [PDF]
How we know what we (think we) know
RE Wittes
JCO Jun 1 1986: 827–829. [PDF]
	Second acute leukemia and other malignancies following treatment for Hodgkin's disease
	P Valagussa, A Santoro, F Fossati-Bellani, A Banfi, and G Bonadonna
	JCO Jun 1 1986: 830–837. [Abstract] [PDF]
	Alternating cycles of combination chemotherapy for patients with recurrent Hodgkin's disease following radiotherapy. A prospectively randomized study by the Cancer and Leukemia Group B
	V Vinciguerra, KJ Propert, M Coleman, JR Anderson, L Stutzman, TF Pajak, NI Nissen, G Frizzera, A Gottlieb, and JF Holland
	JCO Jun 1 1986: 838–846. [Abstract] [PDF]
	Combined modality therapy for adults with small noncleaved cell lymphoma (Burkitt's and non-Burkitt's types)
	JI Bernstein, CN Coleman, JG Strickler, RF Dorfman, and SA Rosenberg
	JCO Jun 1 1986: 847–858. [Abstract] [PDF]
	Tumor burden assessment and its implication for a prognostic model in advanced diffuse large-cell lymphoma
	S Jagannath, WS Velasquez, SL Tucker, LM Fuller, PW McLaughlin, JT Manning, LB North, and FC Cabanillas
	JCO Jun 1 1986: 859–865. [Abstract] [PDF]
	Gastrointestinal involvement and multiple lymphomatous polyposis in mantle-zone lymphoma
	PL Triozzi, MJ Borowitz, and JP Gockerman
	JCO Jun 1 1986: 866–873. [Abstract] [PDF]
	Unusual thoracic radiographic findings in children treated for Hodgkin's disease
	MS Jochelson, NJ Tarbell, and HJ Weinstein
	JCO Jun 1 1986: 874–882. [Abstract] [PDF]
	Phase I-II study of recombinant alpha-2 interferon against advanced leukemia and lymphoma in children
	J Ochs, M Abromowitch, S Rudnick, and SB Murphy
	JCO Jun 1 1986: 883–887. [Abstract] [PDF]
	Consolidation and maintenance therapy in multiple myeloma: randomized comparison of a new approach to therapy after initial response to treatment
	HJ Cohen, AA Bartolucci, WB Forman, and HR Silberman
	JCO Jun 1 1986: 888–899. [Abstract] [PDF]
	Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients
	HM Golomb, A Jacobs, A Fefer, H Ozer, J Thompson, C Portlock, M Ratain, D Golde, J Vardiman, and JS Burke
	JCO Jun 1 1986: 900–905. [Abstract] [PDF]
	Piperazinedione, total body irradiation, and autologous bone marrow transplantation in chronic myelogenous leukemia
	L Vellekoop, AR Zander, HM Kantarjian, S Jagannath, JP Hester, J Trujillo, KB McCredie, G Zagars, G Spitzer, and KA Dicke
	JCO Jun 1 1986: 906–911. [Abstract] [PDF]
	Isolated granulocytic sarcoma: report of a case and review of the literature
	M Eshghabadi, AM Shojania, and I Carr
	JCO Jun 1 1986: 912–917. [Abstract] [PDF]
	Amsacrine-associated cardiotoxicity: an analysis of 82 cases
	RB Weiss, AJ Grillo-Lopez, S Marsoni, JG Posada, Jr, F Hess, and BJ Ross
	JCO Jun 1 1986: 918–928. [Abstract] [PDF]
	Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of L-phenylalanine mustard (L-PAM) in the management of primary breast cancer
	B Fisher, ER Fisher, and C Redmond
	JCO Jun 1 1986: 929–941. [Abstract] [PDF]
	A quality assessment of randomized control trials of primary treatment of breast cancer
	A Liberati, HN Himel, and TC Chalmers
	JCO Jun 1 1986: 942–951. [Abstract] [PDF]
	Drug resistance in clinical practice: patterns of treatment failure in advanced breast and ovarian cancer
	PR Harnett, F Kirsten, and MH Tattersall
	JCO Jun 1 1986: 952–957. [Abstract] [PDF]
	Randomized trial of tamoxifen alone or combined with aminoglutethimide and hydrocortisone in women with metastatic breast cancer
	JN Ingle, SJ Green, DL Ahmann, HJ Long, JH Edmonson, J Rubin, MN Chang, and ET Creagan
	JCO Jun 1 1986: 958–964. [Abstract] [PDF]
	A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer [published erratum appears in J Clin Oncol 1986 Aug;4(8):1284]
	PF Conte, M Bruzzone, S Chiara, MR Sertoli, MG Daga, A Rubagotti, A Conio, M Ruvolo, R Rosso, and L Santi
	JCO Jun 1 1986: 965–971. [Abstract] [PDF]
	Anxiety levels in patients randomized to adjuvant therapy versus observation for early breast cancer
	BR Cassileth, MW Knuiman, MD Abeloff, G Falkson, EZ Ezdinli, and CR Mehta
	JCO Jun 1 1986: 972–974. [Abstract] [PDF]
	Hyperdiploidy and chromosomal rearrangements define the anaplastic variant of Wilms' tumor
	EC Douglass, AT Look, B Webber, D Parham, JA Wilimas, AA Green, and PK Roberson
	JCO Jun 1 1986: 975–981. [Abstract] [PDF]
	Etoposide (VP-16) and cisplatin in previously treated small-cell lung cancer: clinical trial and in vitro correlates
	G Batist, DN Carney, KH Cowan, SR Veach, M Gilliom, PA Bunn, and DC Ihde
	JCO Jun 1 1986: 982–986. [Abstract] [PDF]
	Serial levels of CA 19-9 and CEA in colonic cancer
	BH Novis, E Gluck, P Thomas, GD Steele, VR Zurawski, Jr, R Stewart, PT Lavin, and N Zamcheck
	JCO Jun 1 1986: 987–993. [Abstract] [PDF]
	Calmodulin: a potential target for cancer chemotherapeutic agents
	WN Hait and JS Lazo
	JCO Jun 1 1986: 994–1012. [Abstract] [PDF]
Maintenance chemotherapy in adult ANLL: is it valid?
JP Lewis
JCO Jun 1 1986: 1013a–1015. [PDF]
Response and survival in clinical trials
GA Omura
JCO Jun 1 1986: 1013b. [PDF]
Long-term follow-up of individuals undergoing allogeneic bone marrow transplantation for acute lymphocytic leukemia
WG Woods, NK Ramsay, and JH Kersey
JCO Jun 1 1986: 1015a–1016. [PDF]
Can intraperitoneal chemotherapy alter the natural course of ovarian cancer?
U Beller, EM Beckman, and JL Speyer
JCO Jun 1 1986: 1015b. [PDF]
Multiple drug antiemetic therapy
H Ekert, PA Carden, and SL Mitchell
JCO Jun 1 1986: 1016. [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.